TY - JOUR
T1 - Juvenile dermatomyositis
T2 - Pathophysiology and disease expression
AU - Pachman, L. M.
N1 - Funding Information:
This article was supported in part by the Marlene Apfelbaum Foundation, #NIH/ NIAMS #P60-AR-30692, and the Arthritis Foundation Clinical Science Grant.
PY - 1995
Y1 - 1995
N2 - In summary, the child who develops the symptoms of the specific rash, proximal muscle weakness, or fatigue should seek medical care promptly. With the advances in physical and medical therapy, many of the consequences of the disease can now be ameliorated. Data suggest that JDMS and PM may each have a different pathophysiology, but more evidence is needed. The next few years will be exciting as there is a national effort by an increased number of investigators to determine the epidemiologic and genetic factors that influence JDMS disease susceptibility and severity.
AB - In summary, the child who develops the symptoms of the specific rash, proximal muscle weakness, or fatigue should seek medical care promptly. With the advances in physical and medical therapy, many of the consequences of the disease can now be ameliorated. Data suggest that JDMS and PM may each have a different pathophysiology, but more evidence is needed. The next few years will be exciting as there is a national effort by an increased number of investigators to determine the epidemiologic and genetic factors that influence JDMS disease susceptibility and severity.
UR - http://www.scopus.com/inward/record.url?scp=0028874736&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028874736&partnerID=8YFLogxK
U2 - 10.1016/S0031-3955(16)40054-4
DO - 10.1016/S0031-3955(16)40054-4
M3 - Article
C2 - 7567187
AN - SCOPUS:0028874736
VL - 42
SP - 1071
EP - 1098
JO - Pediatric Clinics of North America
JF - Pediatric Clinics of North America
SN - 0031-3955
IS - 5
ER -